Implementation of a quality management system for decentralized manufacturing of cell and gene therapy products - technical and regulatory considerations

Decentralized manufacturing has emerged as a promising approach to improve the accessibility and scalability of cell and gene therapy products, particularly for autologous treatments. This paper proposes a comprehensive Quality Management System (QMS) framework tailored to decentralized cell therapy...

Full description

Saved in:
Bibliographic Details
Main Authors: Heiko von der Leyen, Julio Delgado, Chaya Mazouz, Michael Schmitt, Vered Caplan
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2025.1591751/full
Tags: Add Tag
No Tags, Be the first to tag this record!